Gomez Francisco, Veita Jesyree, Laudanski Krzysztof
Department of Neurology, University of Missouri, Columbia, MO 65021, USA.
Society for Healthcare Innovation, Philadelphia, PA 19146, USA.
Antibiotics (Basel). 2022 Mar 4;11(3):338. doi: 10.3390/antibiotics11030338.
Extracorporeal membrane oxygenation (ECMO) is an emerging treatment modality associated with a high frequency of antibiotic use. However, several covariables emerge during ECMO implementation, potentially jeopardizing the success of antimicrobial therapy. These variables include but are not limited to: the increased volume of distribution, altered clearance, and adsorption into circuit components, in addition to complex interactions of antibiotics in critical care illness. Furthermore, ECMO complicates the assessment of antibiotic effectiveness as fever, or other signs may not be easily detected, the immunogenicity of the circuit affects procalcitonin levels and other inflammatory markers while disrupting the immune system. We provided a review of pharmacokinetics and pharmacodynamics during ECMO, emphasizing practical application and review of patient-, illness-, and ECMO hardware-related factors.
体外膜肺氧合(ECMO)是一种新出现的治疗方式,抗生素使用频率较高。然而,在ECMO实施过程中会出现几个协变量,可能危及抗菌治疗的成功。这些变量包括但不限于:分布容积增加、清除改变、吸附到回路组件中,以及重症疾病中抗生素的复杂相互作用。此外,ECMO使抗生素疗效评估变得复杂,因为发热或其他体征可能不易检测到,回路的免疫原性会影响降钙素原水平和其他炎症标志物,同时扰乱免疫系统。我们综述了ECMO期间的药代动力学和药效学,重点强调了实际应用以及对患者、疾病和ECMO硬件相关因素的综述。